HLF:NYSEHerbalife Ltd. Analysis
Data as of 2026-09-29 - not real-time
$12.44
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $12.44, Herbalife Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has gained 3.8% over the past 30 days. Momentum indicators put RSI at 54.0 (neutral) with MACD reading bullish. Price has been bracketed by support at $10.96 and resistance at $13.17.
Multiples put this in undervalued territory at a P/E of 8.0. The average analyst target implies 36.7% above today's level. Revenue is growing at 5.4% on a 3.2% profit margin.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 51.6%, a beta of 1.15 and a maximum drawdown of 44.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Multiples put this in undervalued territory at a P/E of 8.0. The average analyst target implies 36.7% above today's level. Revenue is growing at 5.4% on a 3.2% profit margin.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 51.6%, a beta of 1.15 and a maximum drawdown of 44.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions...LOS ANGELES, September 08, 2026--Herbalife Ltd.Check out the companies making headlines yesterday:
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 14.10
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 14.10
- Analyst targets imply +36.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +36.7% versus the current price
- P/E ratio of 8.0
- 30-day volatility of 51.6%
Key Metrics & Analysis
Financial Health
Revenue Growth5.40%
Profit Margin3.16%
P/E Ratio8.0
ROA11.27%
P/B Ratio-2.7
Op. Cash Flow$383.8M
Free Cash Flow$317.9M
Technical Analysis
TrendBearish
RSI54.0
Support$10.96
Resistance$13.17
MA 20$12.15
MA 50$12.19
MA 200$14.10
MACDBullish
VolumeDecreasing
Fear & Greed Index92.79
Valuation
Fair Value$27.88
Target Price$17.00
Upside/Downside36.66%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.15
Volatility51.63%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.